QuidelOrtho (QDEL) Income from Continuing Operations (2021 - 2024)
QuidelOrtho (QDEL) reported Income from Continuing Operations of 1706000000.0 for Q1 2024, down 3595.9% on a YoY basis from 48800000.0 in Q2 2023, and down 222.8% sequentially from 528500000.0 in Q4 2023.
QuidelOrtho (QDEL) Income from Continuing Operations (2021 - 2024) Analysis & Trends
QuidelOrtho (QDEL) has 4 years of Income from Continuing Operations data on file, last reported at 1706000000.0 in Q1 2024.
- For the quarter ending Q1 2024, Income from Continuing Operations fell 3595.9% year-over-year to 1706000000.0; the trailing twelve-month figure through Mar 2024 stood at 2300400000.0 (down 1131.11% YoY), and the FY2024 full-year result was 2052000000.0, down 20216.83% from the prior year.
- Income from Continuing Operations declined to 1706000000.0 in Q1 2024, from 528500000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 479900000.0 in Q2 2022 to a low of 1706000000.0 in Q1 2024.
- A 4-year average of 123872727.27 and a median of 19200000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations rose 1.05% in 2022 and plunged 3595.9% in 2024, its largest moves.
- Tracing QDEL's Income from Continuing Operations over 4 years: stood at 215700000.0 in 2021, then slumped by 91.1% to 19200000.0 in 2022, then tumbled by 2852.6% to 528500000.0 in 2023, then sank by 222.8% to 1706000000.0 in 2024.
- Business Quant data shows QDEL's Income from Continuing Operations at 1706000000.0 in Q1 2024, 528500000.0 in Q4 2023, and 12700000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | -528.50 Mn |
| Oct 1, 2023 | -12.70 Mn |
| Jul 2, 2023 | -53.20 Mn |
| Apr 2, 2023 | 48.80 Mn |
| Jan 1, 2023 | 135.80 Mn |
| Oct 2, 2022 | 19.20 Mn |
| Jul 3, 2022 | 19.30 Mn |
| Apr 3, 2022 | 479.90 Mn |
| Oct 3, 2021 | 215.70 Mn |
| Jul 4, 2021 | 19.10 Mn |